{"organizations": [], "uuid": "d671f971552eb9923e29cd03a19d9d571a5faa8f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180201.html", "section_title": "Archive News &amp; Video for Thursday, 01 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/mckesson-results/update-1-drug-distributor-mckessons-quarterly-profit-beats-estimates-idUSL4N1PR4AZ", "country": "US", "domain_rank": 408, "title": "CORRECTED-UPDATE 1-Drug distributor McKesson's quarterly profit beats estimates", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-02-01T20:35:00.000+02:00", "replies_count": 0, "uuid": "d671f971552eb9923e29cd03a19d9d571a5faa8f"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/mckesson-results/update-1-drug-distributor-mckessons-quarterly-profit-beats-estimates-idUSL4N1PR4AZ", "ord_in_thread": 0, "title": "CORRECTED-UPDATE 1-Drug distributor McKesson's quarterly profit beats estimates", "locations": [], "entities": {"persons": [{"name": "anuron kumar mitra", "sentiment": "none"}, {"name": "maju samuel", "sentiment": "none"}], "locations": [{"name": "manas mishra", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}, {"name": "north america", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "mckesson corp", "sentiment": "negative"}, {"name": "mckesson", "sentiment": "negative"}, {"name": "walmart", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "(Corrects paragraph 5 to say net income rose 42.6 pct, not 42.5 pct)\nFeb 1 (Reuters) - McKesson Corp posted a better-than-expected quarterly profit, as the biggest U.S. drug distributor continues to benefit from its tie-up with Walmart .\nMcKesson and Walmart came together in 2016 to exert their combined negotiating power when buying generic drugs.\nMcKesson said its third-quarter results were also buoyed by growth in most of its segments. The companyâ€™s North America distribution business, its biggest, rose 8 percent.\nTotal revenue increased about 7 percent to $53.62 billion.\nNet income attributable to McKesson jumped 42.6 percent to $903 million, or $4.33 per share, in the quarter ended Dec. 31.\nExcluding items, McKesson earned $3.41 per share, above the average analyst estimate of $2.94, according to Thomson Reuters I/B/E/S.\nThe company also narrowed its 2018 adjusted earnings forecast range to between $12.50 and $12.80 per share, from $11.80 to $12.50 as a result of a lower tax rate and share count. (Reporting by Anuron Kumar Mitra and Manas Mishra; Editing by Maju Samuel)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-01T20:35:00.000+02:00", "crawled": "2018-02-02T12:49:19.003+02:00", "highlightTitle": ""}